|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s9D8BE88C-5D3B-11EF-A40F-008685CE164B&I=39IZM&T=&OP=Display&O=html&O1=15480000&O2=954927570820&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DCLINICAL%2520CONSIDERATIONS%2520ON%2520A%2520NEW%2520SEMISYNTHETIC%2520PENICILLIN%2520%25285-METHYL-3-PHENYL-4-ISOXAZOLYL-PENICILLIN%2520OR%2520OXACILLIN%2529%26rft.au%3DBALESTRIERI%252C%2520G%26rft.au%3DMATANO%252C%2520F%26rft.au%3DSCIOLI%252C%2520C%26rft.date%3D1964-06-13%26rft.externalDocID%3D14170868%26rft.genre%3Darticle%26rft.issn%3D0035-5259%26rft.jtitle%3DLa%2520Riforma%2520medica%26rft.spage%3D658%26rft.volume%3D78%26rft_id%3Dinfo%253Apmid%252F14170868%26rft_id%3Dinfo%253Apmid%252F14170868%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-REFWORKS_EXPORT_TOOL-getReference-object,4-NCBI_PUBMED_FREE-getCitedRecord-object,5-GOOGLE_SCHOLAR_FREE-getWebSearch-object,6-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.265556&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15480000-s9D8BE88C-5D3B-11EF-A40F-008685CE164B" timestamp="2024-08-18T10:26:50Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954927570820</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>[CLINICAL CONSIDERATIONS ON A NEW SEMISYNTHETIC PENICILLIN (5-METHYL-3-PHENYL-4-ISOXAZOLYL-PENICILLIN OR OXACILLIN)].</jnl:atitle>
<jnl:jtitle>La Riforma Medica</jnl:jtitle>
<jnl:date>1964-06-00</jnl:date>
<jnl:spage>658</jnl:spage>
<jnl:epage>660</jnl:epage>
<jnl:coden>RIMEAB</jnl:coden>
<jnl:issn>0035-5259</jnl:issn>
<jnl:volume>78</jnl:volume>
<jnl:genre>article</jnl:genre>
<jnl:eissn>0035-5259</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>RIMEAB</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:921e097bd96cb358cd5cfb025968f35b5710ff35</ctx:identifier>
<ctx:identifier>urn:UUID:s9D8BE88C-5D3B-11EF-A40F-008685CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)